Tag
biotechnology
- Nektar Therapeutics wins US$90M jury award in Lilly licence case
- Scribe Therapeutics develops one‑time cholesterol treatment without permanent gene editing
- White House cuts data centers, batteries from critical technology list
- Definium Therapeutics soars on Phase 3 trial win with LSD depression drug
- Canada launches CAD$900 million defence strategy to advance quantum and AI capabilities
- Allarity Therapeutics doses first patients in VA‑funded small cell lung cancer trial
- Corvus rally continues as clinical optimism offsets dilution concerns
- Researchers replicate natural immune signaling to improve cancer immunotherapy
- Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients
- Galleri shows promise in large U.S. based clinical trial
- Evaxion shares spike as AI‑designed melanoma vaccine data hits market
- Inovio advances DNA medicine for debilitating respiratory condition
- 180 Life Sciences shares spike 76% on crypto company rebrand
- Puma Biotechnology shares get favourable price bump on strong Q2 results
- Y‑mAbs stock soars over 100% after acquisition deal with SERB S.A.S.
- Lantern Pharma completes Japanese enrolment for lung cancer drug trial
- Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans
- Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer
- Supernus Pharmaceuticals picks up embattled Sage Therapeutics
- QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics
- Phase Scientific International advances urine biopsy tech with $34M fundraising round
- Breath tests could soon become key diagnosis tool for multiple diseases
- Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
- Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze?
- TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
- Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future
- RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement
- Personalis Inc share price jumps 50% on deals with Merck and Moderna
- Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial
- Portage Biotech soars after initiating proceedings for iOx Therapeutics sale
- Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate
- Breath Diagnostics onboards new president and closes critical financing
- South Korea's Yuhan has 690% profit spike on U.S. lung cancer drug sales
- Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days
- Wave Life Sciences brings big biotech breakthrough with RNA editing therapy
- Rani Therapeutics enjoys 50% bump on insider buying spree
- The five front war against cancer: A mugglehead roundup
- Scholar Rock stock skyrockets on successful phase 3 trial results
- Capricor Therapeutics gains traction with impending treatment data reveal in Czechia
- Onconetix shares go way up on Altos Ventures investment and stock split
- Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy
- Prelude Therapeutics Incorporated shares drop 30% on clinical trial news
- Why are Viridian Therapeutics shares on the rise on Tuesday?
- Relay Therapeutics shares soar on positive results for breast cancer treatment
- Breath Diagnostics pioneers novel lung cancer breath test
- Kapoose Creek Bio uses AI to identify new fungi-based drugs for brain health
- Investors flock to psychedelic start‑ups
- Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research
- LumiraDX expands the commercial expansion of its diabetes test
- ChitogenX completes opening phases of rotator cuff clinical trial